What is Lupin Ltd (LUPIN) share price today?

Lupin Ltd (LUPIN) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/LUPIN for the latest live price, technical analysis, and AI-powered insights.

How to analyse LUPIN stock?

VestAI provides comprehensive LUPIN stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Lupin Ltd in?

Lupin Ltd (LUPIN) is in the Healthcare sector, Pharmaceuticals industry on the NSE.

Lupin Ltd

Q: What is Lupin Ltd's Orion Score?

Lupin Ltd has an Orion Score of 67/100 (Quality) — a fundamentals-based quality & risk score. Lupin Ltd scores 67/100 (Quality) on the Orion Score — moderate business quality (68), strong growth (76), strong balance-sheet safety (70) and fair valuation (52). A fundamentals-based quality & risk score, not a buy/sell recommendation.

LUPIN

NSE· Healthcare

₹2,496.30

-7.00 (-0.28%)

Updated 12:32 pm IST

52W Low · ₹1,836.8052W High · ₹2,526.90

Near 52W High

Market Cap

₹103686.62L Cr

Volume

5.68L

Prev Close

₹2,503.30

ISIN

INE326A01037

Orion Score

Fundamentals-based quality & risk · not a recommendation

67/100

Quality

Lupin Ltd scores 67/100 (Quality) on the Orion Score — moderate business quality (68), strong growth (76), strong balance-sheet safety (70) and fair valuation (52). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 1.5× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 6/9Altman Z Safe(7.65)Beneish M Clean(-2.59)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

95/100

Strong

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.29x — lean balance sheet

QUALITY

High Quality

ROCE 57.1% — excellent capital efficiency

MOMENTUM

Bullish

RSI 66.3 — strong momentum

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 19.49
ROCE: 57.10%
ROE (1Y): 26.91%
D/E Ratio: 0.29x
OPM: 23.33%
TTM EPS: ₹116.33
Dividend Yield: 53.00%
Qtrly Sales: ₹7,391.91 Cr
Qtrly Profit: ₹1,460.34 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹7,391.91	₹1,460.34	23.3%	₹31.89
Q3 2026	₹7,100.45	₹1,175.55	26.7%	₹25.67
Q1 2026	₹6,163.75	₹1,219.03	52.4%	₹26.62
Q4 2025	₹5,562.2	₹772.52	16.2%	₹16.87
Q3 2025	₹5,618.56	₹855.16	19.5%	₹18.69

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2026	₹27,487.54	₹5,332.84	₹8,682.54	53.4%
FY 2025	₹22,192.11	₹3,281.62	₹5,479.13	18.5%
FY 2024	₹19,656.34	₹1,914.48	₹3,898.12	14.2%
FY 2023	₹16,269.98	₹430.08	₹1,837.39	5.5%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
LUPIN ★	₹1,03,687 Cr	19.49	57.10%	26.91%	0.29x	23.33%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹90,029 Cr	25.94	12.55%	9.93%	0.21x	15.11%
ABBOTINDIAAbbott India Limited	₹57,724 Cr	36.63	36.14%	34.46%	0.04x	27.01%
AJANTPHARMAjanta Pharma Limited	₹41,836 Cr	39.55	27.99%	25.39%	0.06x	51.40%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹29,204.88	₹23,997.18	₹22,955.93	₹21,821.22
Equity	₹17,203.5	₹14,290.29	₹12,464.5	₹12,153.27
Total Debt	₹5,447.77	₹2,921.77	₹4,541.52	₹4,158.38
Cash	₹1,930.78	₹1,187.6	₹1,277.82	₹1,089.92
Net Debt	₹3,145.87	₹1,482.31	₹2,966.23	₹2,754.24
Working Capital	₹7,837.19	₹4,946.15	₹3,185.93	₹4,181.24

Shareholding Pattern

Q1 FY2027

Promoter

47.03%

FII

18.07%

DII

14.78%

Public

20.12%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	47.03% ↑	18.07% ↓	14.78% ↓	20.12% ↑
Q3 FY2026	46.89%	21.5% ↑	25.58% ↓	6.04% ↓
Q2 FY2026	46.89%	20.5% ↓	26.56% ↑	6.06% ↓
Q1 FY2026	46.9%	21.25% ↓	25.55% ↑	6.28% ↑
Q4 FY2025	46.91% ↓	21.46% ↓	25.41% ↑	6.21% ↓
Q3 FY2025	46.94% ↓	22.04% ↑	24.73% ↓	6.27% ↓
Q2 FY2025	46.96% ↓	21.5% ↑	25.1% ↓	6.44% ↓
Q1 FY2025	46.99%	19.32%	26.77%	6.92%

Corporate Actions

Ex-Date	Action	Details
2026-07-17	DIVIDEND	Dividend - Rs 18 Per Share

Funds Holding This Stock

202 mutual fund schemes

Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct GrowthMOTILAL_OSWAL

9.15%

₹3 Cr

Tata Nifty MidSmall Healthcare Index Fund Direct GrowthTATA

9.15%

₹16 Cr

Nippon India Pharma Fund Direct GrowthRELIANCE

7.31%

₹631 Cr

ICICI Prudential Nifty Pharma Index Fund Direct GrowthICICI_PRUDENTIAL

6.16%

₹8 Cr

Baroda BNP Paribas Health and Wellness Fund Direct GrowthBARODABNPPARIBASMUTUALFUND_MF

5.83%

₹32 Cr

HDFC Pharma And Healthcare Fund Direct GrowthHDFC

5.45%

₹129 Cr

DSP Nifty Healthcare Index Fund Direct GrowthDSP

5.27%

₹1 Cr

Motilal Oswal Manufacturing Fund Direct GrowthMOTILAL_OSWAL

5.19%

₹36 Cr

Motilal Oswal Quant Fund Direct GrowthMOTILAL_OSWAL

4.35%

₹11 Cr

Mirae Asset Healthcare Fund Direct GrowthMIRAE_ASSET

4.28%

₹132 Cr

Analyse LUPIN with Orion AI

Ask: "Is Lupin Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Lupin Ltd (LUPIN) Stock

Lupin Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE326A01037. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.